“To improve neonatal care, future research on optimizing the content of PN and decreasing the incidence IFALD and CLASBIs is required.” Calkins et al (2014).
Calkins, K.L., Venick, R.S. and Devaskar, S.U. (2014) Complications Associated with Parenteral Nutrition in the Neonate. Clinics in Perinatology. 41(2), p.331-345.
Complications associated with parenteral nutrition in the neonate http://ctt.ec/7UEQd+ @ivteam #ivteam
Although parenteral nutrition (PN) is life-sustaining, it is associated with many complications including parenteral nutrition-associated liver disease (PNALD) and central line-associated bloodstream infections (CLASBIs), which carry a high morbidity and mortality and impose a burden on the health care system. Evidence has emerged that the dose and composition of intravenous lipid products may alter the incidence of PNALD. However, other patient and PN-related factors, such as prematurity, birth weight, and gastrointestinal anatomy and function, are important. To improve neonatal care, future research on optimizing the content of PN and decreasing the incidence IFALD and CLASBIs is required.
Other intravenous and vascular access resources that may be of interest (External links – IVTEAM has no responsibility for content).
- Guide for intravenous chemotherapy and associated vascular access devices from Macmillan.
- CancerUK IV chemotherapy information.